Skip to content
josep_m_guiu_spd2

Affiliation

Consortium of Health and Social Care of Catalonia

Country

Spain

1. Current Status, Position

Dr. Josep M Guiu is currently Director of the Pharmacy and Medicines area at the Consortium of Health and Social Care of Catalonia. Dr. Guiu is also Associate Professor of Clinical Pharmacy and Pharmaceutical Care at the Faculty of Pharmacy and Food Sciences of the University of Barcelona. He is also currently Vice president for Europe of the International Pharmacetuical Federation (FIP) Hospital Pharmacy Section.

2. Education

He studied Pharmacy at the University of Barcelona and became a licensed pharmacist in 2006. Dr. Josep M Guiu completed his hospital pharmacy residency at Vall d’Hebron University Hospital and obtained the hospital pharmacy specialisation in 2011. He is also Board-Certified in Oncology Pharmacist (BCOP) and a Board-Certified Pharmacotherapy Specialist (BCPS) by the Board of Pharmacy Specialties. He has completed several postgraduate courses and master’s programmes in the fields of clinical pharmacy, health management and digital health.

3. Research Area

His research focuses on drug procurement and sustainable procurement of drugs, drug access and clinical management. He is also working in several projects related to the advancement of practices of the hospital pharmacy profession.

4. Conflict of interest

None

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.